AdlerMwMini review: opioid peptides. Life Sciences1980;26: 497–510.
2.
PertC.SnyderS.Opiate receptor: demonstration in nervous tissue. Science1973;179: 1011–1014.
3.
SimonEjHillerJmEdelmanI.Stereospecific binding of the opiate potent narcotic analgesic (3H) etorphine to rat brain homogenate. Proceedings of the National Academy of Science, USA1973;70:1947–1949.
4.
HughesJ.SmithTwKosterlitzHwFothergillLaMorrisHrMorganBaIdentification of two related pentapeptides from the brain with potent opiate agonist activity. Nature1975;258: 577–579.
5.
BloomF.SegalD.LingN.GuilleminR.Endorphins: profound behavioural effects in rats suggest new etiological factors in mental illness. 1976;194:630–632.
6.
JacquetYfMarksN.The C-fragment of B-lipotropin: an endogenous neuroleptic or antipsychotogen. Science1976;194: 632–636.
GernerRhCatlinDhGorelickDaHuiKkLiChB-endorphin: Intravenous infusion causes behavioural change. Archives of General Psychiatry1980;37: 642–647.
9.
VolavkaJ.DavisLgEhrlichYhEndorphins, dopamine and schizophrenia. Schizophrenia Bulletin1979;5: 227–239.
10.
KastinAjOlsonRdSchallyAvC.N.S. effects of peripherally administered brain peptides. Life Sciences1979;25: 410–414.
11.
TregearGwCoughlanJpEnkephalin, endorphin and the opiate receptor. Supplement I; Circulation Research1980;46:142–148.
12.
MorleyJeThe endocrinology of the opiates and opioid peptides. Metabolism1981;30: 195–209.
13.
WayL.GlascowC.Recent developments in morphine analgesia: tolerance and dependence. In: LiptonMadi MascioA.KfKillam eds. Psychopharmacology: A Generation of Progress. New York, Ravens Press1978.
14.
BrambillaF.GennazzaniArFacchinettiF.ParriniD.PetragliaF.SacchettiE.ScaroneS.GuastallaA.D'AntonaN.B-endorphin and B-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disorders. Psychoneuroendocrinology1981;6: 321–330.
15.
VolavkaJ.Action of naloxone and naltrexone in different types of psychoses. In: HmEmrich ed. The Role of Endorphins in Neuropsychiatry. Basel, Karger1981.